A920: Thyroid: Papillary carcinoma

Similar documents
Thyroid Cancer. What is thyroid cancer? The thyroid gland

THYROID CANCER. I. Introduction

Thyroid Cancer. What is cancer?

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

Advances in Differentiated Thyroid Cancer

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

A912: Kidney, Renal cell carcinoma

Thyroid and Adrenal Gland

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

Pediatric Oncology for Otolaryngologists

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Kidney Cancer OVERVIEW

A918: Prostate: adenocarcinoma

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

Goiter. This reference summary explains goiters. It covers symptoms and causes of the condition, as well as treatment options.

Cancer of the Thyroid Explained

Primary -Benign - Malignant Secondary

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

TNM Staging of Head and Neck Cancer and Neck Dissection Classification

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

Thyroid Cancer Overview

Morphological Variants of Papillary Carcinoma of Thyroid

Understanding Metastatic Disease

Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

Thyroid Disorders. Hypothyroidism

Report series: General cancer information

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual

Frequently Asked Questions About Ovarian Cancer

Lung Cancer: Diagnosis, Staging and Treatment

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Neuroendocrine Tumors

Lymph Nodes and Cancer What is the lymph system?

OBJECTIVES By the end of this segment, the community participant will be able to:

Early Prostate Cancer: Questions and Answers. Key Points

Four Important Facts about Kidney Cancer

Cervical Cancer The Importance of Cervical Screening and Vaccination

95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in

A Focus on Thyroid Cancer

Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed

Cancer of the Cervix

Salivary Gland Cancer

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

LOYOLA UNIVERSITY MEDICAL CENTER RESIDENCY PROGRAM IN GENERAL SURGERY CLINICAL ROTATION DESCRIPTION

Releasing Nuclear Medicine Patients to the Public: Dose Calculations and Discharge Instructions

Cancer doesn t care but we do Cancer Annual Report

Thyroid Cancer Basics

Us TOO University Presents: Understanding Diagnostic Testing

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Your Guide to the Breast Cancer Pathology Report

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,

The TV Series. INFORMATION TELEVISION NETWORK

THYROID DISEASE IN CHILDREN

Symptoms of Hodgkin lymphoma

Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions

Avastin: Glossary of key terms

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

loving life YOUR GUIDE TO YOUR THYROID

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

How common is bowel cancer?

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

KIDNEY CANCER (ADULT) - RENAL CELL CARCINOMA

YOUR LUNG CANCER PATHOLOGY REPORT

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

Immunohistochemical differentiation of metastatic tumours

Small Cell Lung Cancer

How CanCer becomes critical in the claims

Kidney Cancer (Adult) - Renal Cell Carcinoma What is cancer?

Kidney Cancer (Adult) - Renal Cell Carcinoma What is cancer?

BIOBANK LPCE-NICE CHEST

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Gallbladder Diseases and Problems

THYROID NODULES, BUMPS, & LUMPS: WHEN IS MEDICAL THERAPY A USEFUL OPTION? Michael R. Broome DVM, DABVP

Anaplastic Thyroid Cancer:

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.

National Cancer Institute

PATIENT GUIDE. Localized Prostate Cancer

Male. Female. Death rates from lung cancer in USA

Update on Mesothelioma

Pathology of lung cancer

Thyroid Problems after Childhood Cancer

Frozen Section Diagnosis

Understanding. Pancreatic Cancer

Evaluation of the Thyroid Nodule

Transcription:

A920: Thyroid: Papillary carcinoma General facts of lung cancer The thyroid gland is located under the Adam's apple in the front part of the neck. In most people it cannot be seen or felt. It has 2 lobes, called the right lobe and the left lobe, joined by a narrow isthmus. This gland takes up iodine from the diet and the blood and makes a thyroid hormone important for many body functions. The thyroid gland contains mainly 2 types of cells: -Thyroid follicle cells actually make and store thyroid hormone. They also make a special thyroid protein called thyroglobulin. -C cells make another hormone, calcitonin. Different cancers develop from each kind of cell. The differences are important because they determine the seriousness of the cancer and the type of treatment needed. Many types of tumors can develop in the thyroid gland. Most of these tumors are benign, or noncancerous. Others are cancerous, which means they can spread into nearby tissues and to other parts of the body. Because the thyroid gland is close to the skin, tumors often appear as bumps in the neck. They are called thyroid nodules. Thyroid nodules can develop at any age, but they are most common in adults, occurring in one third of all people. Often people find these bumps themselves by seeing or feeling them. Other times they are never noticed and never cause a problem. Benign Thyroid Tumors Almost all (95%) of thyroid nodules or tumors are benign. They develop from thyroid follicular cells and can be found in normal-sized thyroid glands and goiters (enlarged thyroid glands). The thyroid may contain 1 nodule or several nodules. A gland with several benign nodules is called a multinodular goiter. Often these nodules are cysts filled with fluid, or they may be "lumps" of stored thyroid hormone called colloid nodules. Colloid nodules have very few cells in them. Other nodules may have too many cells, but the cells are not cancer cells. This type of nodule includes hyperplastic nodules and adenomas. Sometimes hyperplastic nodules or adenomas make too much thyroid hormone, causing a condition called hyperthyroidism. Symptoms of hyperthyroidism include nervousness, irregular and rapid beating of the heart, excessive sweating, and weight loss. But even these nodules are not cancerous.

Malignant Thyroid Tumors Only 5% to10% of thyroid nodules are cancerous. There are several types of thyroid cancer. Papillary carcinoma and follicular carcinoma are the most common. Some doctors group these together and call them differentiated thyroid cancer or well-differentiated thyroid cancer. Medullary carcinoma, H?thle cell carcinoma (a subtype of follicular carcinoma), anaplastic carcinoma, and thyroid lymphoma occur less often. Papillary carcinoma: About 80% to 85% of thyroid cancers are papillary carcinomas (also called papillary cancer or papillary adenocarcinoma). Papillary carcinomas develop from the thyroid follicle cells and typically grow very slowly. Usually they occur in only one lobe of the thyroid gland, but about 10% to 20% of the time both lobes are involved. Several different variants (subtypes) of papillary carcinoma can be recognized under the microscope. These include the follicular variant, tall cell variant, columnar cell variant, and diffuse sclerosing variant. The usual form of papillary adenocarcinoma and the follicular variant have the same outlook for survival ( prognosis), and treatment is the same for both. The other variants tend to spread more quickly and have a worse prognosis. Even though papillary cancer grows slowly, it often spreads early to the lymph nodes in the neck. Fortunately, most people with papillary cancer do not die from it. Follicular carcinoma: Follicular carcinoma is the next most common type of thyroid cancer. It is also sometimes called follicular cancer or follicular adenocarcinoma. Follicular cancer is much less common than papillary thyroid cancer, making up about 5% to 10% of thyroid cancers. It is more common in countries where people don't get enough iodine in their diet. These cancers usually remain in the thyroid gland but can spread to other parts of the body, such as lungs and bone. Unlike papillary carcinoma, follicular carcinomas spread to lymph nodes less often. The prognosis of follicular carcinoma is probably the same or slightly worse than that of papillary carcinoma. H?thle cell carcinoma, also known as oxyphil cell carcinoma, is thought to be a subtype of follicular cancer and has about the same survival outlook. Anaplastic carcinoma: Anaplastic carcinoma is an uncommon form of thyroid cancer. It is believed to develop from an existing papillary or follicular cancer. It is an aggressive cancer that rapidly invades the neck, often spreads to other parts of the body, and is usually fatal. Anaplastic carcinoma is sometimes called undifferentiated thyroid cancer. Both of these names indicate that, under the microscope, they have very little, if any, similarity to normal thyroid tissue. In contrast, the similarity of differentiated thyroid cancer to normal thyroid tissue is easily seen under the microscope.

Medullary thyroid carcinoma: Medullary thyroid carcinoma (MTC) is the only thyroid cancer that develops from the C cells of the thyroid gland. Sometimes this cancer can spread to lymph nodes, the lungs, or liver even before a thyroid nodule is discovered or a screening test is done. These cancers usually make calcitonin and carcinoembryonic antigen (CEA). Calcitonin, a hormone also produced by normal C cells, helps control the amount of calcium in blood. CEA is a protein produced by certain cancers, such as colorectal cancer and MTC. Both the blood and can be found by blood tests. About 5% of thyroid cancers are medullary. There are 2 types of MTC. The first type, occurring in 80% of cases, is called sporadic MTC. Sporadic MTC is not inherited; that is, it does not run in families. It occurs mostly in older adults and in only 1 thyroid lobe. The other type of MTC is inherited and can occur in each generation of a family. When MTC is the only type of cancer found in the family, it is called isolated familial medullary thyroid carcinoma (FMTC). The combination of FMTC and tumors of certain other organs is called type 2 multiple endocrine neoplasia (MEN 2). Type 2 MEN has 2 subtypes, MEN 2a and MEN 2b: -In MEN 2a, MTC occurs with adrenal gland tumors called pheochromocytomas and with parathyroid gland tumors that cause high blood calcium levels. The adrenal glands are found next to the upper part of each kidney. Most people have 4 parathyroid glands, which are found next to the thyroid. -In MEN 2b, MTC is associated with pheochromocytoma but not parathyroid gland disease. Instead, MEN 2b includes benign growths of nerve tissues on the tongue and elsewhere called neuromas. In these familial or genetic forms of MTC, the cancers often develop during childhood or early adulthood and can spread early. MTC is most aggressive in the MEN 2b syndrome. Thyroid lymphoma: Lymphoma can develop in the thyroid gland but is very uncommon in that location. It does not develop from either thyroid follicular cells or C cells. Rather, lymphomas develop from lymphocytes, the main cell type of the immune system. Most lymphocytes are found in pea-sized collections scattered throughout the body called lymph nodes, and that is where most lymphomas begin. These types of lymphomas are discussed in the ACS document on Non-Hodgkin Lymphoma.

Primary tumor (T) Staging of thyroid cancer TX: Primary tumor cannot be assessed T0: No evidence of primary tumor : Tumor 1 cm or less in greatest dimension limited to the thyroid T2: Tumor more than 1 cm but not more than 4 cm in greatest dimension limited to the thyroid T3: Tumor more than 4 cm in greatest dimension limited to the thyroid T4: Tumor of any size extending beyond the thyroid capsule Regional lymph nodes (N) Regional lymph nodes are the cervical and upper mediastinal lymph nodes. NX: Regional lymph nodes cannot be assessed N0: No regional lymph node metastasis : Regional lymph node metastasis a: Metastasis in ipsilateral cervical lymph node(s) b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s) Distant metastases (M) Papillary or follicular Under 45 years Stage I Any T, any N, M0 Stage II Any T, any N, M1 45 years and older Stage I, N0, M0 Stage II T2, N0, M0 T3, N0, M0 Stage III T4, N0, M0 Any T,, M0 Stage IV Any T, any N, M1 Medullary Stage I, N0, M0 Stage II T2, N0, M0 T3, N0, M0 T4, N0, M0 Stage III Any T,, M0 Stage IV Any T, any N, M1 Undifferentiated (anaplastic) All cases are stage IV Stage IV Any T, any N, any M MX: Distant metastasis cannot be assessed M0: No distant metastasis M1: Distant metastasis References 1. Thyroid Gland. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven Publishers, 1997, pp 59-64.

A920: thyroid: papillary carcinoma Lot. No : 120213050611 Fig2. RT-PCR for GAP3DH Sample : Serial 10 sections of 10micrometer slice Fig 1. Scanned images for H&E stained slides. RNA conc. (ng/ul) 624.41 142.61 260/280 1.98 1.97 Pathology or other information: AGE: 37 Sex: Female Stage: T2aM0 Pathology: 1.Thyroid gland, lobectomy: Papillary carcinoma 1) extension to the capsule, but not penetrated. 2) size: 3x2.2cm.

A920: thyroid: papillary carcinoma Lot. No : 120214012711 N2 T2 T T N N Fig2. RT-PCR for GAP3DH Sample : Serial 10 sections of 10micrometer slice Fig 1. Scanned images for H&E stained slides. T2 N2 RNA conc. (ng/ul) 377.87 567.21 102.71 40.18 260/280 1.93 1.9 1.9 1.85 Pathology or other information: AGE: 45 Sex: Female Stage: T3aM0 Pathology: 1.Thyroid gland, left, lobectomy: Papillary carcinoma 1) extension to the perithyroidal soft tissue. 2) lymph node, regional (1/1): Metastatic carcinoma. 3) presence of a parathyroid gland.

A920: thyroid: papillary carcinoma Lot. No : 120214012721 Fig2. RT-PCR for GAP3DH Sample : Serial 10 sections of 10micrometer slice Fig 1. Scanned images for H&E stained slides. RNA conc. (ng/ul) 282.66 133.47 260/280 2 1.9 Pathology or other information: AGE: 71 Sex: Male Stage: T3aM0 Pathology: 1.Thyroid gland, left, lobectomy: Papillary carcinoma 1) encapsulated and follicular variant 2) confined to the parenchyma.

A920: thyroid: papillary carcinoma Lot. No : 1202104010811 Fig 1. Scanned images for H&E stained slides. Fig2. RT-PCR for GAP3DH Sample : Serial 10 sections of 10micrometer slice RNA conc. (ng/ul) 327.8 138.65 260/280 2 1.98 Pathology or other information: AGE: 70 Sex: Female Stage: N0M0 Pathology: 1.Thyroid gland, frozen lobectomy: Papillary carcinoma, follicular variant, with capsular invasion.